Aberrant activation of mesenchymal epithelial transition factor (MET) and phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) has been shown to correlate with a wide range of malignant behaviors in CRC (Leiphrakpam and Are, 2024). The gene discussed is AKT1; the disease is colorectal carcinoma.